Search

everythinglearnresearchcommunity

for

Search:↓

Azathioprine is the most continued treatment for chronic alopecia areata over a year, often with added low-dose prednisolone.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Cyclosporin A, a drug, reduces TGF-β2 expression in skin cells, potentially causing excessive hair growth through a process involving the calcineurin/NFAT pathway.

Telitacicept helped stabilize complement levels in a patient with lupus and thyroid cancer.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

CS12192 effectively treats alopecia areata with better safety than current options.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Tofacitinib helped a person with total body hair loss grow hair again without bad side effects.

Tofacitinib may effectively treat folliculitis decalvans.

High-dose ciclosporin significantly improved a young cat's severe skin condition.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Both concentrations of triamcinolone acetonide are equally effective and safe for treating patchy alopecia areata.

A man with severe hair loss and skin disease regrew his hair with no side effects after taking tofacitinib.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Intramuscular triamcinolone and pulse therapy with oral predonine are effective for alopecia areata with manageable side effects, but better relapse prevention is needed.

Cyclosporine combined with other treatments can help hair regrow in severe alopecia areata, but it may cause side effects.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Both tofacitinib and ruxolitinib are effective and tolerable for treating alopecia areata.

Tofacitinib and methotrexate successfully treated a woman's severe skin, joint, and hair loss issues.

Tocilizumab therapy may cause skin and hair conditions like halo naevi, vitiligo, and alopecia areata.

A man with severe hair loss regrew all his hair using tofacitinib and stayed healthy for a year.

Oral cyclosporine is more effective and safer than betamethasone for treating alopecia areata.

Ovarian function was similar in both treatment groups, but both caused excessive hair growth.

Oral tofacitinib may effectively regrow hair in children with alopecia areata unresponsive to other treatments.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

Topical cyclosporine significantly extends skin graft survival in rats.